PD-L1 testing and CPS interpretation in squamous cell carcinoma (HNSCC)
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland) [External links]
PDF, 1.15 MB
Download this leaflet for more information on PD-L1 testing and CPS scoring in HNSCC.
CPS = Combined Positive Score; HNSCC = Head and Neck Squamous Cell Carcinoma
More information about KEYTRUDA® (pembrolizumab) in first-line head and neck squamous cell carcinoma:
Prescribing Information (Great Britain) & Prescribing Information (Northern Ireland)
By clicking the links above you will leave the MSD Connect website and be taken to the emc PI portal website